Tonic B cell antigen receptor signals supply an NF-κB substrate for prosurvival BLyS signaling
- 2 November 2008
- journal article
- research article
- Published by Springer Nature in Nature Immunology
- Vol. 9 (12) , 1379-1387
- https://doi.org/10.1038/ni.1666
Abstract
Mature B cell survival requires signals from the BCR and from the BLyS receptor BR3. Michael Cancro and colleagues demonstrate crosstalk between these pathways, as BCR signals supply a substrate needed for BR3 signal transmission. The survival of transitional and mature B cells requires both the B cell antigen receptor (BCR) and BLyS receptor 3 (BR3), which suggests that these receptors send signals that are nonredundant or that engage in crosstalk with each other. Here we show that BCR signaling induced production of the nonclassical transcription factor NF-κB pathway substrate p100, which is required for transmission of BR3 signals and thus B cell survival. The capacity for sustained p100 production emerged during transitional B cell differentiation, the stage at which BCR signals begin to mediate survival rather than negative selection. Our findings identify a molecular mechanism for the reliance of primary B cells on continuous BR3 and BCR signaling, as well as for the gradual resistance to negative selection that is acquired during B cell maturation.Keywords
This publication has 49 references indexed in Scilit:
- The role of BLyS/BLyS receptors in anti-chromatin B cell regulationInternational Immunology, 2007
- A Fourth IκB Protein within the NF-κB Signaling ModuleCell, 2007
- Selectivity of BAFF/BLyS and APRIL for Binding to the TNF Family Receptors BAFFR/BR3 and BCMABiochemistry, 2005
- T-cell-receptor- and B-cell-receptor-mediated activation of NF-κB in lymphocytesCurrent Opinion in Immunology, 2004
- The Orally Available Spleen Tyrosine Kinase Inhibitor 2-[7-(3,4-Dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide Dihydrochloride (BAY 61-3606) Blocks Antigen-Induced Airway Inflammation in RodentsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- RelB/p50 Dimers Are Differentially Regulated by Tumor Necrosis Factor-α and Lymphotoxin-β Receptor ActivationJournal of Biological Chemistry, 2003
- BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cellsNature Immunology, 2002
- p50–NF-κB Complexes Partially Compensate for the Absence of RelB: Severely Increased Pathology in p50−/−relB−/−Double-knockout MiceThe Journal of Experimental Medicine, 1997
- bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice.The Journal of Experimental Medicine, 1996
- Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase InhibitorJournal of Biological Chemistry, 1996